Psychological Neuromodulatory Treatments for Young People with Chronic Pain
Abstract
:1. Introduction
2. Neurofeedback
2.1. Definition and Procedures
2.2. Effects
2.3. Conclusions
3. Meditation
3.1. Definition and Procedures
3.2. Effects
3.3. Conclusions
4. Hypnosis
4.1. Definition and Procedures
4.2. Effects
4.3. Conclusions
5. Conclusions and General Discussion
Acknowledgments
Conflicts of Interest
References
- Van Dijk, A.; McGrath, P.A.; Pickett, W.; VanDenKerkhof, E.G. Pain prevalence in nine- to 13-year-old school children. Pain Res. Manag. 2006, 11, 234–240. [Google Scholar] [CrossRef] [PubMed]
- Huguet, A.; Miró, J. The severity of chronic pediatric pain: An epidemiological study. J. Pain 2008, 9, 226–236. [Google Scholar] [CrossRef] [PubMed]
- Stevens, B.J.; Zempsky, W.T. Prevalence and distribution of pain in children. In Oxfor Textbook of Paediatric Pain; McGrath, P.J., Stevens, B.J., Walker, S.M., Zempsky, W.T., Eds.; Oxford University Press: Oxford, UK, 2014; pp. 12–19. [Google Scholar]
- Huguet, A.; Eccleston, C.; Miró, J.; Gauntlett-Gilbert, J. Young people making sense of pain: Cognitive appraisal, function, and pain in 8–16 year old children. Eur. J. Pain 2009, 13, 751–759. [Google Scholar] [CrossRef] [PubMed]
- Solé, E.; Castarlenas, E.; Miró, J. A Catalan adaptation and validation of the Pain Catastrophizing Scale for Children. Psychol. Assess. 2016, 28, e119–e126. [Google Scholar] [CrossRef] [PubMed]
- De la Vega, R.; Racine, M.; Sánchez-Rodríguez, E.; Tomé-Pires, C.; Castarlenas, E.; Jensen, M.P.; Miró, J. Pain Extent, Pain Intensity, and Sleep Quality in Adolescents and Young Adults. Pain Med. 2016, 17, 1971–1977. [Google Scholar] [CrossRef] [PubMed]
- De la Vega, R.; Miró, J. The assessment of sleep in pediatric chronic pain sufferers. Sleep Med. Rev. 2013, 17, 185–192. [Google Scholar] [CrossRef] [PubMed]
- Miró, J.; Huguet, A.; Jensen, M.P. Pain beliefs predict pain intensity and pain status in children: Usefulness of the pediatric version of the survey of pain attitudes. Pain Med. 2014, 15, 887–897. [Google Scholar] [CrossRef] [PubMed]
- Miró, J.; Huguet, A.; Nieto, R. Predictive factors of chronic pediatric pain and disability: A Delphi poll. J. Pain 2007, 8, 774–792. [Google Scholar] [CrossRef] [PubMed]
- Castarlenas, E.; de la Vega, R.; Tomé-Pires, C.; Solé, E.; Racine, M.; Jensen, M.P.; Miró, J. Student Expectations of Peer and Teacher Reactions to Students With Chronic Pain: Implications for Improving Pain-related Functioning. Clin. J. Pain 2015, 31, 992–997. [Google Scholar] [CrossRef] [PubMed]
- Forgeron, P.A.; King, S.; Stinson, J.N.; McGrath, P.J.; MacDonald, A.J.; Chambers, C.T. Social functioning and peer relationships in children and adolescents with chronic pain: A systematic review. Pain Res. Manag. 2010, 15, 27–41. [Google Scholar] [CrossRef] [PubMed]
- Logan, D.E.; Simons, L.E.; Carpino, E.A. Too sick for school? Parent influences on school functioning among children with chronic pain. Pain 2012, 153, 437–443. [Google Scholar] [CrossRef] [PubMed]
- Roth-Isigkeit, A.; Thyen, U.; Stoven, H.; Schwarzenberger, J.; Schmucker, P. Pain among children and adolescents: Restrictions in daily living and triggering factors. Pediatrics 2005, 115, e152–e162. [Google Scholar] [CrossRef] [PubMed]
- Huguet, A.; Miró, J. Development and psychometric evaluation of a Catalan self- and interviewer-administered version of the Pediatric Quality of Life Inventory version 4.0. J. Pediatr. Psychol. 2008, 33, 63–79. [Google Scholar] [CrossRef] [PubMed]
- Rabbitts, J.A.; Holley, A.L.; Groenewald, C.B.; Palermo, T.M. Association Between Widespread Pain Scores and Functional Impairment and Health-Related Quality of Life in Clinical Samples of Children. J. Pain 2016, 17, 678–684. [Google Scholar] [CrossRef] [PubMed]
- Vowles, K.E.; Cohen, L.L.; McCracken, L.M.; Eccleston, C. Disentangling the complex relations among caregiver and adolescent responses to adolescent chronic pain. Pain 2010, 151, 680–686. [Google Scholar] [CrossRef] [PubMed]
- Hunfeld, J.A.; Perquin, C.W.; Duivenvoorden, H.J.; Hazebroek-Kampschreur, A.A.; Passchier, J.; van Suijlekom-Smit, L.W.; van der Wouden, J.C. Chronic pain and its impact on quality of life in adolescents and their families. J. Pediatr. Psychol. 2001, 26, 145–153. [Google Scholar] [CrossRef] [PubMed]
- Groenewald, C.B.; Wright, D.R.; Palermo, T.M. Health care expenditures associated with pediatric pain-related conditions in the United States. Pain 2015, 156, 951–957. [Google Scholar] [CrossRef] [PubMed]
- Stinson, J.; Bruce, E. Chronic pain in children. In Managing Pain in Children. A Clinical Guide; Twycross, A., Dowden, S., Bruce, E., Eds.; Wiley-Blackwell: Chichester, UK, 2009; pp. 145–170. [Google Scholar]
- Gregoiré, M.C.; Finley, G.A. Drugs for chronic pain in children: A commentary on clinical practice and the absence of evidence. Pain Res. Manag. 2013, 18, 47–51. [Google Scholar]
- Unruh, A.; McGrath, P.J. History of pain in children. In Oxford Textbook of Paediatric Pain; McGrath, P.J., Stevens, B.J., Walker, S.M., Zempski, W.T., Eds.; Oxford University Press: Oxford, UK, 2014; pp. 3–11. [Google Scholar]
- Carter, B.D.; Threlkeld, B.M. Psychosocial perspectives in the treatment of pediatric chronic pain. Pediatr. Rheumatol. Online J. 2012, 10, 15. [Google Scholar] [CrossRef] [PubMed]
- McGrath, P.; Stevens, B.; Walker, S.; Zempsky, W. Oxford Textbook of Paediatric Pain; Oxford University Press: London, UK, 2013. [Google Scholar]
- American pain Society Assessment and Management of Children with Chronic Pain. A Position Statement Am. Pain Soc. 2012.
- Jensen, M.P.; Day, M.A.; Miró, J. Neuromodulatory treatments for chronic pain: Efficacy and mechanisms. Nat. Rev. Neurol. 2014, 10, 167–178. [Google Scholar] [CrossRef] [PubMed]
- International Society for Neurofeedback and Research Definition of Neurofeedback. Definition of ISNR Board of Directors. Available online: http://www.isnr.org/neurofeedback-introduction (accessed on 10 June 2016).
- Sherlin, L.H.; Arns, M.; Lubar, J.; Heinrich, H.; Kerson, C.; Strehl, U.; Sterman, M.B. Neurofeedback and Basic Learning Theory: Implications for Research and Practice. J. Neurother. 2011, 15, 292–304. [Google Scholar] [CrossRef]
- Teplan, M. Fundamentals of EGG measurement. Rev. Meas. Sci. 2002, 2, 1–11. [Google Scholar]
- Heinrich, H.; Gevensleben, H.; Strehl, U. Annotation: Neurofeedback—Train your brain to train behaviour. J. Child Psychol. Psychiatry 2007, 1, 3–16. [Google Scholar] [CrossRef] [PubMed]
- Hammond, D.C. What is neurofeedback: An update. J. Neurother. 2011, 15, 305–336. [Google Scholar] [CrossRef]
- Hammond, D.C. What Is Neurofeedback? J. Neurother. Investig. Neuromodulation Neurofeedback Appl. Neurosci. 2007, 10, 25–36. [Google Scholar] [CrossRef]
- Pinheiro, E.S.; Queirós, F.C.; Montoya, P.; Santos, C.L.; do Nascimento, M.A.; Ito, C.H.; Silva, M.; Nunes Santos, D.B.; Benevides, S.; Miranda, J.G.; et al. Electroencephalographic Patterns in Chronic Pain: A Systematic Review of the Literature. PLoS ONE 2016, 11, e0149085. [Google Scholar] [CrossRef] [PubMed]
- Hassan, M.A.; Fraser, M.; Conway, B.A.; Allan, D.B.; Vuckovic, A. The mechanism of neurofeedback training for treatment of central neuropathic pain in paraplegia: A pilot study. BMC Neurol. 2015, 1–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Koberda, J.L.; Koberda, P.; Bienkiewicz, A.A.; Moses, A.; Koberda, L. Pain Management Using 19-Electrode Z-Score LORETA Neurofeedback. J. Neurother. 2013, 17, 179–190. [Google Scholar] [CrossRef]
- Santoro, M.M.; Cronan, T.A. Systematic Review of Neurofeedback as a Treatment for Fibromyalgia Syndrome Symptoms. J. Musculoskelet. Pain 2014, 22, 286–300. [Google Scholar] [CrossRef]
- Kayiran, S.; Dursun, E.; Dursun, N.; Ermutlu, N.; Karamürsel, S. Neurofeedback Intervention in Fibromyalgia Syndrome; a Randomized, Controlled, Rater Blind Clinical Trial. Appl. Psychophysiol. Biofeedback 2010, 35, 293–302. [Google Scholar] [CrossRef] [PubMed]
- Siniatchkin, M.; Hierundar, A.; Kropp, P.; Kuhnert, R.; Gerber, W.D.; Stephani, U. Self-regulation of slow cortical potentials in children with migraine: An exploratory study. Appl. Psychophysiol. Biofeedback 2000, 25, 13–32. [Google Scholar] [CrossRef] [PubMed]
- Stokes, D.A.; Lappin, M.S. Neurofeedback and biofeedback with 37 migraineurs: A clinical outcome study. Behav. Brain Funct. 2010, 6, 9. [Google Scholar] [CrossRef] [PubMed]
- Lutz, A.; Slagter, H.A.; Dunne, J.D.; Davidson, R.J. Attention regulation and monitoring in meditation. Trends Cogn. Sci. 2008, 12, 163–169. [Google Scholar] [CrossRef] [PubMed]
- Kabat-Zinn, J. Mindfulness-Based Interventions in Context: Past, Present, and Future. Clin. Psychol. Sci. Pract. 2003, 10, 144–156. [Google Scholar] [CrossRef]
- Kabat-Zinn, J. Wherever You Go, There You Are: Mindfulness Meditation in Everyday Life; Hyperion: New York, NY, USA, 1994. [Google Scholar]
- Segal, Z.V.; Williams, J.M.G.; Teasdale, J.D. Mindfulness-Based Cognitive Therapy for Depression: A New Approach to Preventing Relapse; Guilford Press: London, UK, 2002. [Google Scholar]
- Hayes, S.C.; Strosahl, K.D.; Wilson, K.G. Acceptance and Commitment Therapy: An Experiential Approach to Behavior Change; The Guilford Press: New York, NY, USA, 1999. [Google Scholar]
- Burke, C.A. Mindfulness-based approaches with children and adolescents: A preliminary review of current research in an emergent field. J. Child Fam. Stud. 2010, 19, 133–144. [Google Scholar] [CrossRef]
- Kallapiran, K.; Koo, S.; Kirubakaran, R.; Hancock, K. Review: Effectiveness of mindfulness in improving mental health symptoms of children and adolescents: A meta-analysis. Child Adolesc. Ment. Health 2015, 20, 182–194. [Google Scholar] [CrossRef]
- Jones, P.; Blunda, M.; Biegel, G.; Carlson, L.E.; Biel, M.; Wiener, L. Can mindfulness based interventions help adolescents with cancer? Psychooncology 2013, 22, 2148–2151. [Google Scholar] [CrossRef] [PubMed]
- Ames, C.S.; Richardson, J.; Payne, S.; Smith, P.; Leigh, E. Mindfulness-based cognitive therapy for depression in adolescents. Child Adolesc. Ment. Health 2014, 19, 74–78. [Google Scholar] [CrossRef]
- Rosenzweig, S.; Greeson, J.M.; Reibel, D.K.; Green, J.S.; Jasser, S.A.; Beasley, D. Mindfulness-based stress reduction for chronic pain conditions: Variation in treatment outcomes and role of home meditation practice. J. Psychosom. Res. 2010, 68, 29–36. [Google Scholar] [CrossRef] [PubMed]
- Chiesa, A.; Serretti, A. Mindfulness-based interventions for chronic pain: A systematic review of the evidence. J. Altern. Complement. Med. 2011, 17, 83–93. [Google Scholar] [CrossRef] [PubMed]
- Hesse, T.; Holmes, L.G.; Kennedy-Overfelt, V.; Kerr, L.M.; Giles, L.L. Mindfulness-Based Intervention for Adolescents with Recurrent Headaches: A Pilot Feasibility Study. Evid.-Based Complement. Altern. Med. 2015, 2015, 1–9. [Google Scholar] [CrossRef] [PubMed]
- Jastrowski, K.E.; Salamon, K.S.; Hainsworth, K.R.; Anderson Khan, K.J.; Ladwig, R.J.; Davies, W.H.; Weisman, S.J. A randomized, controlled pilot study of mindfulness-based stress reduction for pediatric chronic pain. Altern. Ther. Health Med. 2013, 19, 8–14. [Google Scholar]
- Ruskin, D.; Ahola Kohut, S.; Stinson, J. The development of a mindfulness-based stress reduction group for adolescents with chronic pain. J. Pain Manag. 2015, 7, 301–312. [Google Scholar]
- Gauntlett-Gilbert, J.; Connell, H.; Clinch, J.; McCracken, L.M. Acceptance and values-based treatment of adolescents with chronic pain: Outcomes and their relationship to acceptance. J. Pediatr. Psychol. 2013, 38, 72–81. [Google Scholar] [CrossRef] [PubMed]
- Martin, S.; Wolters, P.L.; Toledo-Tamula, M.A.; Schmitt, S.N.; Baldwin, A.; Starosta, A.; Gillespie, A.; Widemann, B. Acceptance and commitment therapy in youth with neurofibromatosis type 1 (NF1) and chronic pain and their parents: A pilot study of feasibility and preliminary efficacy. Am. J. Med. Genet. A 2016, 170, 1462–1470. [Google Scholar] [CrossRef] [PubMed]
- Elkins, G.R.; Barabasz, A.F.; Council, J.R.; Spiegel, D. Advancing Research and Practice: The Revised APA Division 30 Definition of Hypnosis. Am. J. Clin. Hypn. 2015, 57, 378–385. [Google Scholar] [CrossRef] [PubMed]
- Weitzenhoffer, A.M. The Practice of Hypnotism, 2nd ed.; John Wiley & Sons: New York, NY, USA, 1989. [Google Scholar]
- Derbyshire, S.W.; Whalley, M.G.; Oakley, D.A. Fibromyalgia pain and its modulation by hypnotic and non-hypnotic suggestion: An fMRI analysis. Eur. J. Pain 2009, 13, 542–550. [Google Scholar] [CrossRef] [PubMed]
- Tomé-Pires, C.; Miró, J. Hypnosis for the management of chronic and cancer procedure-related pain in children. Int. J. Clin. Exp. Hypn. 2012, 60, 432–457. [Google Scholar] [CrossRef] [PubMed]
- Rutten, J.M.; Reitsma, J.B.; Vlieger, A.M.; Benninga, M.A. Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: A systematic review. Arch. Dis. Child. 2013, 98, 252–257. [Google Scholar] [CrossRef] [PubMed]
- Jensen, M.P.; Patterson, D.R. Hypnotic approaches for chronic pain management: Clinical implications of recent research findings. Am. Psychol. 2014, 69, 167–177. [Google Scholar] [CrossRef] [PubMed]
- Hawkins, R.M. A systematic meta-review of hypnosis as an empirically supported treatment for pain. Pain Rev. 2001, 8, 47–73. [Google Scholar] [CrossRef]
- Galili, O.; Shaoul, R.; Mogilner, J. Treatment of chronic recurrent abdominal pain: Laparoscopy or hypnosis? J. Laparoendosc. Adv. Surg. Tech. A 2009, 19, 93–96. [Google Scholar] [CrossRef] [PubMed]
- Kohen, D.P.; Zajac, R. Self-Hypnosis Training for Headaches in Children and Adolescents. J. Pediatr. 2007, 150, 635–639. [Google Scholar] [CrossRef] [PubMed]
- Anbar, R.D.; Zoughbi, G.G. Relationship of headache-associated stressors and hypnosis therapy outcome in children: A retrospective chart review. Am. J. Clin. Hypn. 2008, 50, 335–341. [Google Scholar] [CrossRef] [PubMed]
- Zeltzer, L.K.; Tsao, J.C.; Stelling, C.; Powers, M.; Levy, S.; Waterhouse, M. A Phase I Study on the Feasibility and Acceptability of an Acupuncture/Hypnosis Intervention for Chronic Pediatric Pain. J. Pain Symptom Manag. 2002, 24, 437–446. [Google Scholar] [CrossRef]
- Van Tilburg, M.A.; Chitkara, D.K.; Palsson, O.S.; Turner, M.; Blois-Martin, N.; Ulshen, M.; Whitehead, W.E. Audio-recorded guided imagery treatment reduces functional abdominal pain in children: A pilot study. Pediatrics 2009, 124, e890–e897. [Google Scholar] [CrossRef] [PubMed]
- Vlieger, A.M.; Menko-Frankenhuis, C.; Wolfkamp, S.C.; Tromp, E.; Benninga, M.A. Hypnotherapy for Children With Functional Abdominal Pain or Irritable Bowel Syndrome: A Randomized Controlled Trial. Gastroenterology 2007, 133, 1430–1436. [Google Scholar] [CrossRef] [PubMed]
- Vlieger, A.M.; Rutten, J.M.; Govers, A.M.; Frankenhuis, C.; Benninga, M.A. Long-term follow-up of gut-directed hypnotherapy vs. standard care in children with functional abdominal pain or irritable bowel syndrome. Am. J. Gastroenterol. 2012, 107, 627–631. [Google Scholar] [CrossRef] [PubMed]
- Weydert, J.A.; Shapiro, D.E.; Acra, S.A.; Monheim, C.J.; Chambers, A.S.; Ball, T.M. Evaluation of guided imagery as treatment for recurrent abdominal pain in children: A randomized controlled trial. BMC Pediatr. 2006, 6, 29. [Google Scholar] [CrossRef] [PubMed]
- Olness, K.; MacDonald, J.T.; Uden, D.L. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics 1987, 79, 593–597. [Google Scholar] [PubMed]
- Chambless, D.L.; Baker, M.J.; Baucom, D.H.; Beutler, L.E.; Calhoun, K.S.; Crits-christoph, P.; Daiuto, A.; Derubeis, R.; Detweiler, J.; Haaga, D.A.F.; et al. Update on Empirically Validated Therapies, II. Clin. Psychol. 1998, 51, 3–16. [Google Scholar]
- Tomé-Pires, C.; Solé, E.; Racine, M.; de la Vega, R.; Castarlenas, E.; Jensen, M.; Miró, J. Use of hypnotic techniques in children and adolescents with chronic pain: Do age of patients, and years of practice and theoretical orientation of clinicians matter? Int. J. Clin. Exp. Hypn. 2016, 64, 1–16. [Google Scholar] [CrossRef] [PubMed]
- Lang, E.V.; Benotsch, E.G.; Fick, L.J.; Lutgendorf, S.; Berbaum, M.L.; Berbaum, K.S.; Logan, H.; Spiegel, D. Adjunctive non-pharmacological analgesia for invasive medical procedures: A randomised trial. Lancet (Lond. Engl.) 2000, 355, 1486–1490. [Google Scholar] [CrossRef]
- Jensen, M.P. Hypnosis for Chronic Pain Management: Therapist Guide; Oxford University Press: Oxford, UK, 2011. [Google Scholar]
- Jensen, M.P.; Patterson, D.R. Hypnotic approaches for chronic pain management: Clinical implications of recent research findings. Am. Psychol. 2014, 69, 167–177. [Google Scholar] [CrossRef] [PubMed]
- Richardson, J.; Smith, J.E.; McCall, G.; Pilkington, K. Hypnosis for procedure-related pain and distress in pediatric cancer patients: A systematic review of effectiveness and methodology related to hypnosis interventions. J. Pain Symptom Manag. 2006, 31, 70–84. [Google Scholar] [CrossRef] [PubMed]
- Jensen, M.P.; Adachi, T.; Tomé-Pires, C.; Lee, J.; Osman, Z.J.; Miró, J. Mechanisms of hypnosis: Toward the development of a biopsychosocial model. Int. J. Clin. Exp. Hypn. 2015, 63, 34–75. [Google Scholar] [CrossRef] [PubMed]
- McGrath, P.J.; Walco, G.A.; Turk, D.C.; Dworkin, R.H.; Brown, M.T.; Davidson, K.; Eccleston, C.; Finley, G.A.; Goldschneider, K.; Haverkos, L.; et al. Core Outcome Domains and Measures for Pediatric Acute and Chronic/Recurrent Pain Clinical Trials: PedIMMPACT Recommendations. J. Pain 2008, 9, 771–783. [Google Scholar] [CrossRef] [PubMed]
Author(s) Country | Neuromodulatory Treatment/Study Design | Group and Intervention Description | Sample Description | Assessment Points and Outcome/Process Variables | Summary of Key Findings |
---|---|---|---|---|---|
Siniatchkin et al. [37] Germany | NF Non-randomized pilot study | Groups G1: NF treatment G2: Healthy controls G3: Waiting list Session details Number of sessions: 1 introductory session + 10 training sessions over 8 weeks. Session content:
| G1: n = 10 80% male Mean age = 10.5 years Dx.: Migraine without aura G2: n = 10 70% male Mean age = 11.6 years Dx.: Healthy children G3: n = 10 80% male Mean age = 9.9 years Dx.: Migraine without aura | Assessment points
Outcome variables
| 50% of the treatment group presented a 50% or greater reduction in the number of migraines a month after treatment. Migraine duration reductions were observed in treatment and waiting list groups. No significant changes in the waiting list group in accompanying symptoms (nausea, vomiting, intensity of migraine, or medication intake). No significant differences between the treatment group and the waiting list group in medication intake and migraine intensity. Successful suppression of SCPs’ amplitude in the treatment group. |
Stokes & Lappin [38] USA | NF Case series | One group only NF + pirHEG + medication Session details Number of sessions: 40 sessions (30 NF + 10 pirHEG/thermal feedback) Session content:
| n = 13 70% female Mean age = 13.4 years Age range = 9–21 years Dx.: Migraine | Assessment points
Outcome variable
| Significant decreases observed in the average number of migraine days from pre-treatment to follow-up. |
Gauntlett-Gilbert et al. [53] United Kingdom | Meditation Case series | One group only ACT residential pain management program Session details Sessions duration: 90 h over 3 weeks Session content:
| n = 98 75% female Mean age = 15.6 years Age range = 10.8–19.0 years Dx.: Idiopathic pain, complex regional pain syndrome, back pain, abdominal pain, pain associated with hypermobility | Assessment points
Outcome variables
| Significant pre- to post-treatment improvements observed in physical and social disability, walking distance, pain anxiety, pain catastrophizing, pain acceptance, school attendance and medication use that were maintained at follow-up. Significant pre- to post-treatment improvements in depression and perceived psychosocial development were observed, but these improvements were not maintained at follow-up. Significant pre- to follow up decrease in health care use. No significant differences in pain intensity at post-treatment and follow-up. |
Hesse et al. [50] USA | Meditation Case series | One group only MBSR Session details Number of sessions: 8 weekly sessions Session duration: 2 h Session content:
| n = 20 100% female Mean age = 14.15 years Age range = 11–16 years Dx.: Headache | Assessment points
Process variables
Outcome variables
| Average number of sessions attended: 6.10 of 8 total sessions. Average of adherence to daily meditation practice: 4.69 of 6 practices per week. Number (%) who completed treatment: 15 (75%). 53% reported the treatment was helpful in coping with stress, relaxing and controlling their emotions and pain; 40% reported that it was helpful in specific ways (i.e., pain reduction); 13% reported the intervention was not as helpful as expected. 33% reported the intervention not affect their headache, 20% reported having fewer headaches, 13.3% reported having less severe headache, and 7% the headache got better. Significant pre- to post-treatment improvements were observed in depressive symptoms and pain willingness. No significant pre- to post-treatment differences were observed in frequency and severity of headache, disability, quality of life, anxiety, or activity engagement. |
Jastrowski et al. [51] USA | Meditation Randomized pilot (i.e., very small sample size) study | Groups G1: MBSR G2: Psycho-educational group Session details Number of sessions: 6 weekly sessions Session duration: 90’ Session content: G1:
G2:
| G1: N = 4 75% female Mean age = 15.0 years Age range = 12–17 year. Dx.: Chest pain, extremity pain, headache pain, back pain G2: N = 2 100% female Mean age = 12.5 years Age range = 12–13 years Dx.: Abdominal pain | Assessment points
Process variables
Outcome variables
| Average number of sessions attended: G1: 4/6 sessions G2: 3/6 sessions In general, participants had positive expectations of the proposed interventions. 75% of the participants in G1 reported expecting that MBSR would be “somewhat” to “completely helpful” at pre-treatment. At 12-week follow-up one participant reported that MBSR was “completely helpful” and another that it was “not at all helpful”. Qualitative individual analyses for outcome variables (data are missing for several participants and for different assessment points) indicate that:
|
Martin et al. [54] USA | Meditation Case series | One group only ACT Session details Number of sessions: 3 Session duration: 2 h over 2 days Session content:
| n = 10 50% girls Mean age = 16.9 years Age range = 12–20 years Dx.: Neurofibromatosis type 1 | Assessment points
Process variables
Outcomes variables Adolescents:
Parents
| 60% of the participants used mindfulness techniques at least once a week at follow-up. Average participant satisfaction with study was 3.9 on a 0–5 scale. Average parent satisfaction with treatment was 4.6 on a 0–5 scale. Significant pre-treatment to follow-up improvements in pain intensity and pain interference were observed. 60% of the participants reported a decrease of medication at follow-up, relative to pre-treatment. Parents reported a significant pre-treatment to follow-up reduction in pain interference. No significant pre-treatment to follow-up improvements were reported in functional ability, anxiety, depression, quality of life by patient or parent reports, and acceptance of child’s pain. |
Ruskin et al. [52] Canada | Meditation Pilot uncontrolled clinical study | One group only MBSR Session details Number sessions: 8 Session duration: 2 h Session content (meditation exercises):
| n = 16 100% girls Mean age = 5.75 years Age range = 13–17 years Dx.: Neurophatic pain, musculoskeletal pain, abdominal pain, mixed pain, headache | Assessment points
Process variables
| Completion rate: 81% Average sessions attendance was 6.4 out of 8 sessions. All participants would recommend the intervention. Average importance of learning and practice mindfulness rated as 4.17 out of 5. Average confidence in use mindfulness rated as 4 out of 5. MBSR rated as being useful to cope with pain and negative emotions and for being more kind with themselves (average rating = 3.67 out of 5). Favorite activities of the treatment included: experiential exercises, meeting others with similar life experiences, group discussions, and learning new techniques to cope with pain. Areas of improvement noted: need of more specific and immediate techniques for managing pain flare-ups, need of more time to share pain stories with other participant, and difficulties with getting to the hospital after a school day. |
Anbar &Zoughbi [64] USA | Hypnosis Case series | One group only Hypnosis Session details Number of sessions: Mean of 2 sessions of hypnosis in clinic with a mean of 3.8 sessions (range 1–16) | n = 30 56.6% female Mean age = 15 years Age range: 10–18 years Dx.: Headache | Assessment points
Outcome variables
| 96% of the participants reported pre- to post-treatment decreases in headache frequency and intensity. Pre- to post-treatment improvements were maintained at follow-up for 65% of the sample. |
Galini, Shaoul & Mogilner [62] Israel | Hypnosis Case series | One group only Hypnosis Session details Number of sessions: 1 | n = 20 75% female Age range = 11–18 years Dx.: Chronic recurrent functional abdominal pain | Assessment points
Outcome variables
| 70% of the participants reported pre- to post-treatment improvements in pain intensity and pain frequency. |
Kohen & Zajac [63] USA | Hypnosis Case series | One group only Hypnosis Session details Number of sessions: 3 to 4 | n = 144 66% female Mean age = 11.0 years Age range = 5–15 years Dx.: Headache | Assessment points
Outcome variables
| 88% of the participants reported a decrease in headache frequency (from 4.5 to 1.4/week), 87% a decrease in headache pain intensity (10.3 to 4.7 in a 12-point scale), and 26% experienced a resolution in their headache. Headache duration decreased from 23.6 to 3.0 h, on average. |
Olness et al. [70] USA | Hypnosis Randomized controlled trial | Groups G1: Placebo-placebo-hypnosis G2: Propranolol-placebo-hypnosis G3: Placebo-propranolol-hypnosis Session details Number of sessions: 3 during 12 weeks, 10-week placebo or drug treatment period. | G1: n = 9 44.4% female Mean age = 8.4 years Age range = 6–12 years Dx.: Migraine G2: n = 11 18.2% female Mean age = 9.6 years Age range = 6–12 years Dx.: Migraine G3: n = 8 62.5% female/male Mean age = 9.6 years Age range = 6–12 years Dx.: Migraine | Assessment points
Outcome variables
| Participants in the hypnosis group reported a significantly greater pre- to post-treatment decrease in headache frequency relative to control group, but no significant differences were found regarding pain intensity. |
Van Tilburg et al. [66] USA | Hypnosis Randomized controlled trial | Groups G1: Standard medical care + listening to recorded hypnotic sessions G2: Standard medical care Session details (G1) Number of sessions: 3 biweekly sessions, including 1 booster session + 3 daily sessions. Treatment period: 2 months Session content: Listen to tape with self-exercises ≥5 days/week. | G1: n = 19 G2: n = 15 71% female Age range = 6–16 years Dx: Functional Abdominal Pain | Assessment points
Outcome variables
| Participants in the hypnosis group reported significantly greater pre- to post-treatment improvements in pain intensity and perceived “health related quality of life” than participants in the control group. No significant differences between the hypnosis and control groups were observed in school absenteeism or medication use. |
Vlieger et al. [67] Vlieger et al. [68] * Netherlands | Hypnosis Randomized controlled trial | Groups G1: Hypnosis G2: Standard medical care + supportive therapy Session details Number of sessions: 6 Session duration: 50’over a 3-month period for the G1. Six 30’ session over a 3-month period for the G2. | G1: n = 27 67% female G2: n = 22 86% female Mean age = 13.2 years Age range = 8–18 years Dx.: Irritable bowel syndrome, functional abdominal pain | Assessment points
Outcome variables
| Participants in the hypnosis group reported significantly greater pre- to post-treatment improvements in pain intensity and frequency. Participants in the hypnosis group reported significantly greater general pain improvement at 1-year and 5-year follow up. No significant differences between the hypnosis and control groups were observed in school absenteeism at a 5-year follow-up. |
Weydert et al. [69] USA | Hypnosis Randomized controlled trial | Groups G1: Standard medical care + 4 hypnosis sessions G2: Standard medical care + breathing techniques Session details Number of sessions: 4 weekly sessions Session content: G1: Progressive relaxation + guided imagery. Listen to tape with self-exercises twice a day. G2: Learning three breathing techniques. | G1: n = 14 77% female Mean age = 11.0 years Dx.: Abdominal pain G2: n = 8 50% female Mean age = 11.1 years Dx.: Abdominal pain | Assessment points
Outcome variables
| Participants in the hypnosis group reported significantly greater pre- to post-treatment improvements in pain frequency that were maintained at 1-month follow up. Participants in the hypnosis group reported significantly greater pre- to post-treatment improvements in school absenteeism that were maintained at 1-month follow up. |
Zeltzer et al. [65] USA | Hypnosis Case series | One group only Hypnosis Session details Number of sessions: 6 weekly sessions Session content: acupuncture combined with 20′ of hypnotic sessions. | n = 31 61% female Mean age = 13 years Age range = 6–18 years Dx.: Headache, abdominal pain associated with irritable bowel syndrome, fibromyalgia, complex regional pain syndrome, juvenile rheumatoid arthritis, myofascial back and chest pain | Assessment points
Outcome variables
| Children: Participants reported significantly greater pre- to post-treatment improvements in current and average pain intensity; 42.5% of children reported a decrease in current pain. Participants reported significantly greater pre- to post-treatment improvements in pain interference in functioning. Participants reported significantly greater pre- to post-treatment improvements in anxiety (50% of children reported decrease). No significant changes were reported in depression. Parents: Parents reported significantly greater pre- to post-treatment improvements in current and average pain intensity as well as pain interference in functioning. |
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Miró, J.; Castarlenas, E.; De la Vega, R.; Roy, R.; Solé, E.; Tomé-Pires, C.; Jensen, M.P. Psychological Neuromodulatory Treatments for Young People with Chronic Pain. Children 2016, 3, 41. https://doi.org/10.3390/children3040041
Miró J, Castarlenas E, De la Vega R, Roy R, Solé E, Tomé-Pires C, Jensen MP. Psychological Neuromodulatory Treatments for Young People with Chronic Pain. Children. 2016; 3(4):41. https://doi.org/10.3390/children3040041
Chicago/Turabian StyleMiró, Jordi, Elena Castarlenas, Rocío De la Vega, Rubén Roy, Ester Solé, Catarina Tomé-Pires, and Mark P. Jensen. 2016. "Psychological Neuromodulatory Treatments for Young People with Chronic Pain" Children 3, no. 4: 41. https://doi.org/10.3390/children3040041
APA StyleMiró, J., Castarlenas, E., De la Vega, R., Roy, R., Solé, E., Tomé-Pires, C., & Jensen, M. P. (2016). Psychological Neuromodulatory Treatments for Young People with Chronic Pain. Children, 3(4), 41. https://doi.org/10.3390/children3040041